IN2012DN06278A - - Google Patents

Info

Publication number
IN2012DN06278A
IN2012DN06278A IN6278DEN2012A IN2012DN06278A IN 2012DN06278 A IN2012DN06278 A IN 2012DN06278A IN 6278DEN2012 A IN6278DEN2012 A IN 6278DEN2012A IN 2012DN06278 A IN2012DN06278 A IN 2012DN06278A
Authority
IN
India
Prior art keywords
polypeptides
directed
present
use production
microalgal cells
Prior art date
Application number
Other languages
English (en)
Inventor
Kirk E Apt
Anne Cecile V BAYNE
James Casey Lippmeier
Xuan Guo
Joyce A Pritchard
Original Assignee
Dsm Ip Assets Bv
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv, Merial Ltd filed Critical Dsm Ip Assets Bv
Publication of IN2012DN06278A publication Critical patent/IN2012DN06278A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18651—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
IN6278DEN2012 2009-12-28 2010-12-28 IN2012DN06278A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29046909P 2009-12-28 2009-12-28
PCT/US2010/062274 WO2011082189A1 (fr) 2009-12-28 2010-12-28 Production de protéine hémagglutinine-neuraminidase dans des microalgues

Publications (1)

Publication Number Publication Date
IN2012DN06278A true IN2012DN06278A (fr) 2015-09-25

Family

ID=44226795

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6278DEN2012 IN2012DN06278A (fr) 2009-12-28 2010-12-28

Country Status (9)

Country Link
US (1) US9012197B2 (fr)
EP (1) EP2519636B8 (fr)
JP (1) JP5838473B2 (fr)
CN (1) CN103068984B (fr)
AU (1) AU2010339544B2 (fr)
CA (1) CA2785867C (fr)
EA (1) EA030095B1 (fr)
IN (1) IN2012DN06278A (fr)
WO (1) WO2011082189A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI324181B (en) 2001-04-16 2010-05-01 Martek Biosciences Corp Product and process for transformation of thraustochytriales microorganisms
CN104263729B (zh) * 2009-03-16 2020-09-15 帝斯曼知识产权资产有限公司 在网粘菌门微生物中产生蛋白质
US10633667B2 (en) * 2009-12-28 2020-04-28 Boehringer Ingelheim Animal Health USA Inc. Recombinant NDV antigen and uses thereof
CA3028175C (fr) * 2009-12-28 2022-05-24 Sanofi Vaccine Technologies, S.A.S. Methodes de production de proteines de neuraminidase virale heterologue dans des microalgues
WO2011090493A1 (fr) 2010-01-19 2011-07-28 Martek Biosciences Corporation Micro-organismes produisant de l'acide eicosapentaénoïque, compositions d'acides gras et leurs procédés de fabrication et d'utilisation
HK1198515A1 (en) * 2011-07-21 2015-05-15 Dsm Ip Assets B.V. Fatty acid compositions
CN103525785B (zh) * 2013-09-24 2015-03-25 西北大学 一种分离纯化神经氨酸酶（禽流感病毒）的方法
EP3265567B1 (fr) 2015-03-02 2020-07-29 Conagen Inc. Éléments de régulation provenant de micro-organismes labyrinthulomycetes
US10457970B2 (en) 2016-11-01 2019-10-29 Conagen Inc. Expression of modified glycoproteins and glycopeptides
US10633454B2 (en) 2016-11-01 2020-04-28 Conagen Inc. Expression of modified glycoproteins and glycopeptides
EP3788164A4 (fr) * 2018-05-01 2022-01-26 Conagen Inc. Organismes recombinants et procédés de production de glycomolécules à forte occupation de glycanes
JP2024542635A (ja) 2021-11-30 2024-11-15 サノフィ パスツール インコーポレイテッド ヒトメタニューモウイルスワクチン

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659669A (en) * 1981-03-02 1987-04-21 Regents Of The Univ. Of California Microbial expression of human influenza hemagglutinin proteins
US4752473A (en) * 1984-10-12 1988-06-21 The Regents Of The University Of California Expression of glycosylated human influenza hemagglutinin proteins
US5340742A (en) * 1988-09-07 1994-08-23 Omegatech Inc. Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
WO1997039106A1 (fr) * 1996-04-12 1997-10-23 Martek Biosciences Corporation Procedes et outils de transformation d'algues eucaryotes
AU8246298A (en) 1997-07-08 1999-02-08 Stichting Instituut Voor Dierhouderij En Diergezondheid Epitopes and active sites of paramyxoviridae proteins and uses thereof
US8003772B2 (en) * 1999-01-14 2011-08-23 Martek Biosciences Corporation Chimeric PUFA polyketide synthase systems and uses thereof
US7625756B2 (en) * 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
ES2252261T3 (es) * 2000-06-28 2006-05-16 Glycofi, Inc. Metodos para producir glicoproteinas modificadas.
US20060257399A1 (en) * 2000-06-28 2006-11-16 Glycofi, Inc. Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform
US20060029604A1 (en) * 2000-06-28 2006-02-09 Gerngross Tillman U Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
US7795002B2 (en) * 2000-06-28 2010-09-14 Glycofi, Inc. Production of galactosylated glycoproteins in lower eukaryotes
TWI324181B (en) * 2001-04-16 2010-05-01 Martek Biosciences Corp Product and process for transformation of thraustochytriales microorganisms
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
KR20060035596A (ko) 2003-05-05 2006-04-26 보이스 톰슨 인스터튜트 포 플랜트 리서치 외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포
KR20060017635A (ko) * 2003-06-05 2006-02-24 와이어쓰 홀딩스 코포레이션 베네쥬엘라 말 뇌염 바이러스 레플리콘 벡터 및파라믹소바이러스 단백질 항원을 포함하는 면역원성 조성물
JP4980895B2 (ja) * 2004-05-25 2012-07-18 メディミューン，エルエルシー インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体
US8936930B2 (en) * 2004-08-05 2015-01-20 Ben-Gurion University Of The Negev Research And Development Authority Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same
JP4796786B2 (ja) * 2005-04-28 2011-10-19 富士フイルム株式会社 ラビリンチュラ類を形質転換可能なベクター
JP4796787B2 (ja) * 2005-04-28 2011-10-19 富士フイルム株式会社 ラビリンチュラ類への遺伝子導入法
KR101524398B1 (ko) * 2006-03-15 2015-06-04 디에스엠 아이피 어셋츠 비.브이. Ｐｕｆａ 폴리케티드 신타제 시스템을 이용한 이종 생물체내 다불포화 지방산의 제조
CA2615372A1 (fr) 2007-07-13 2009-01-13 Marc-Andre D'aoust Particules semblables au virus grippal a comprenant de l'hemagglutinine
EP2090648A1 (fr) * 2008-02-12 2009-08-19 Institut Francais de Recherche pour l'Exploitation de la Mere(Ifremer) Production de polypeptides glycosylés dans des microalgues
CN104263729B (zh) * 2009-03-16 2020-09-15 帝斯曼知识产权资产有限公司 在网粘菌门微生物中产生蛋白质
CA3028175C (fr) * 2009-12-28 2022-05-24 Sanofi Vaccine Technologies, S.A.S. Methodes de production de proteines de neuraminidase virale heterologue dans des microalgues
US10633667B2 (en) * 2009-12-28 2020-04-28 Boehringer Ingelheim Animal Health USA Inc. Recombinant NDV antigen and uses thereof

Also Published As

Publication number Publication date
AU2010339544A1 (en) 2012-08-09
CA2785867A1 (fr) 2011-07-07
EA030095B1 (ru) 2018-06-29
CA2785867C (fr) 2018-03-27
CN103068984B (zh) 2017-12-01
CN103068984A (zh) 2013-04-24
WO2011082189A1 (fr) 2011-07-07
AU2010339544B2 (en) 2015-11-12
JP5838473B2 (ja) 2016-01-06
EP2519636A1 (fr) 2012-11-07
EA201290565A1 (ru) 2013-02-28
JP2013515502A (ja) 2013-05-09
EP2519636A4 (fr) 2013-07-03
US9012197B2 (en) 2015-04-21
US20110195480A1 (en) 2011-08-11
EP2519636B8 (fr) 2017-08-09
EP2519636B1 (fr) 2017-03-01

Similar Documents

Publication Publication Date Title
IN2012DN06278A (fr)
IN2014CN03072A (fr)
IN2014CN02100A (fr)
MX2013001540A (es) Composiciones que comprende un polipeptido que tiene actividad de incremento celulolititico y un compuesto de quinona, y uso de las mismas.
PH12013500760B1 (en) Microorganism producing o-phosphoserine and method of producing l-cysteine or derivatives thereof from o-phosphoserine using the same
JOP20180103B1 (ar) التركيب الصيدلاني للكاربيتوسين
MX339809B (es) Metodo para preparar anticuerpos con propiedades mejoradas.
EA201290567A1 (ru) Получение гетерологичных полипептидов в микроводорослях, внеклеточные микроводорослевые тельца, композиции и способы их получения и применения
IN2014CN00688A (fr)
AU2011356210A8 (en) Novel fucosyltransferases and their applications
SG10201900948PA (en) Modified nucleotide linkers
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
WO2014153346A8 (fr) Ingénierie de cellules souches pluripotentes d'un tissu hétérogène
WO2011159684A3 (fr) Génération de cellules souches pluripotentes induites à partir de petits volumes de sang périphérique
MX2019004568A (es) Produccion mejorada de derivados de acidos grasos.
IN2015KN00262A (fr)
MX341324B (es) Polipeptidos.
IN2014DN06104A (fr)
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
MX2011013112A (es) Solventes novedosos para la produccion de dispersiones de poliuretano.
IN2014DN10710A (fr)
MX2013004981A (es) Composiciones y metodos para la administracion de agentes terapeuticos.
NZ607149A (en) Galacto-oligosaccharide-containing composition and a method of producing it
MX349544B (es) Extractos de maesa japonica y métodos de uso.
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium